行情

XTNT

XTNT

Xtant医控股
AMEX

实时行情|Nasdaq Last Sale

1.120
+0.070
+6.67%
交易中 13:09 09/21 EDT
开盘
1.070
昨收
1.050
最高
1.120
最低
1.060
成交量
5.50万
成交额
--
52周最高
6.58
52周最低
0.7100
市值
9,711.22万
市盈率(TTM)
-9.2486
分时
5日
1月
3月
1年
5年
Xtant Medical 将出席 HC Wainwright 第 23 届年度全球投资大会
BELGRADE, Mont., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne, Chief Executi...
GlobeNewswire · 09/07 12:00
Altium Capital Management LP 收购 Xtant Medical Holdings Inc、Kaleyra Inc、CTI BioPharma Corp、...
GuruFocus News · 08/17 18:38
Xtant Medical 公布 2021 年第二季度财务业绩
Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the second quarter ended June 30, 2021.
GlobeNewswire · 08/05 11:00
-- 盈利快报 (XTNT) XTANT MEDICAL 公布第二季度收入 1500 万美元
MT Newswires · 08/05 07:17
Xtant Medical 将于 2021 年 8 月 5 日发布 2021 年第二季度财务业绩
Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the second quarter ended June 30, 20...
GlobeNewswire · 07/29 20:05
RIOT、MARA、SOS 是上市前的赢家
Chembio Diagnostics (CEMI) +93% on receiving $28.3M purchase order from Bio-Manguinhos for DPP SARS-CoV-2. Antigen Tests in BrazilLexaria Bioscience (LEXX) +42% as DehydraTECH significantly enhances delivery of Colchicine in study VIRAL-A20-3.PainReform (P...
Seekingalpha · 07/21 12:29
今日最大的盘前股票走势:周三的 10 大涨幅和跌幅
Investor Place · 07/21 11:29
XELA、SOHU、SEED 中的工业推动者。
 Gainers: Red Cat Holdings RCAT +97%.Allied Healthcare Products AHPI +82%.Orbsat OSAT +45%.Exela Technologies (XELA) +38%.SCWorx WORX +30%.Virpax Pharmaceuticals VRPX +30%.PLx Pharma PLXP +26%.Howard Bancorp HBMD +28%.Integrated Media Technology (IMTE) +22...
Seekingalpha · 07/13 16:37
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解XTNT最新的财务预测,通过XTNT每股收益,每股净资产,每股现金流等数据分析Xtant医控股近期的经营情况,然后做出明智的投资选择。
分析师评级

1位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测
分析师预测XTNT价格均价为1.000,最高价位1.000,最低价为1.000。
EPS
机构持股
总机构数: 14
机构持股: 1,186.29万
持股比例: 13.68%
总股本: 8,670.73万
类型机构数股数
增持
4
2.26万
建仓
1
15
减持
2
5,678
平仓
0
0
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
医疗设备、用品及经销
+0.36%
医疗设备和用品
+0.54%
高管信息
President/Chief Executive Officer/Director
Sean Browne
Chief Financial Officer/Vice President - Finance
Greg Jensen
Chief Operating Officer
Darrel Holmes
Senior Vice President
Kevin Brandt
Chief Scientific Officer
Gregory Juda
Director
John Bakewell
Director
Michael Eggenberg
Director
Robert McNamara
Director
Jeffrey Peters
Director
Matthew Rizzo
暂无数据
XTNT 简况
Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on designing, developing, and commercializing portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its Orthobiologics Products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoWrap and 3Demin. Its Spinal Implant Products include Cervical products, such as Certex Spinal Fixation System and Spider Cervical Plating System, and Thoracolumbar products, such as Axle Interspinous Fusion System, Silex Sacroiliac Joint Fusion System, Xpress Minimally Invasive Pedicle Screw System and Fortex Pedicle Screw System, and Interbody Products, such as Calix, Axle-X Interspinous Fusion System, Irix-C Cervical Integrated Fusion System and Irix-A Lumbar Integrated Fusion System.

微牛提供Xtant Medical Holdings Inc(AMEX-XTNT)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的XTNT股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易XTNT股票基本功能。